441
113. Loveymi BD, Jelvehgari M, Zakeri-Milani P, Valizadeh H. Statistical optimization of oral
vancomycin-eudragit RS nanoparticles using response surface methodology. Iranian J
Pharmaceut Res. 2012;11(4):1001–12.
114. Mazzarino L, Travelet C, Ortega-Murillo S, Otsuka I, Pignot-Paintrand I, Lemos-Senna E,
et al. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive
applications. J. Colloid Interface Sci. 2012;370(1):58–66.
115. Cascone MG, Lazzeri L, Carmignani C, Zhu Z. Gelatin nanoparticles produced by a simple
W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med. 2002;13(5):523–6.
116. Moradhaseli S, Mirakabadi AZ, Sarzaeem A, Dounighi NM, Soheily S, Borumand
MR. Preparation and characterization of sodium alginate nanoparticles containing ICD-85
(venom derived peptides). Int J Innov Appl Stud. 2013;4(3):534–42.
117. Noorani L, Stenzel M, Liang R, Pourgholami MH, Morris DL. Albumin nanoparticles increase
the anticancer efficacy of albendazole in ovarian cancer xenograft model. J Nanobiotechnol.
2015;13(1):1.
118. Dubey N, Varshney R, Shukla J, Ganeshpurkar A, Hazari PP, Bandopadhaya GP, et al.
Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor
targeted delivery of somatostatin analog. Drug Deliv. 2012;19(3):132–42.
119. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, et al. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007;
28(5):869–76.
120. Zou W, Liu C, Chen Z, Zhang N. Preparation and characterization of cationic PLA-PEG
nanoparticles for delivery of plasmid DNA. Nanoscale Res Lett. 2009;4(9):982.
121. Bathool A, Vishakante GD, Khan MS, Shivakumar H. Development and characterization of
atorvastatin calcium loaded chitosan nanoparticles for sustain drug delivery. Adv Mater Lett.
2012;3(6):466–70.
122. Xue Y, Xu X, Zhang X-Q, Farokhzad OC, Langer R. Preventing diet-induced obesity in mice
by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl
Acad Sci. 2016;113(20):5552–7.
123. Chen H, Ng JP, Tan Y, McGrath K, Bishop DP, Oliver B, et al. Gold nanoparticles improve
metabolic profile of mice fed a high-fat diet. J Nanobiotechnol. 2018;16(1):11.
124. Chen C-C, Tsai T-H, Huang Z-R, Fang J-Y. Effects of lipophilic emulsifiers on the oral
administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 2010;74(3):474–82.
125. Auwal S, Zarei M, Tan C, Basri M, Saari N. Improved in vivo efficacy of anti-hypertensive
biopeptides encapsulated in chitosan nanoparticles fabricated by ionotropic gelation on spontaneously hypertensive rats. Nanomaterials. 2017;7(12):421.
126. Auwal SM, Zarei M, Tan CP, Basri M, Saari N. Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE)-inhibitory biopeptides by chitosan nanoparticles optimized using box-Behnken design. Sci Rep. 2018;8(1):10411.
127. Maximov V, Reukov V, Barry J, Cochrane C, Vertegel A. Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia. Nanotechnology.
2010;21(26):265103.
25 Role of Nanoparticles in the Management of Metabolic Disorders
113. Loveymi BD, Jelvehgari M, Zakeri-Milani P, Valizadeh H. Statistical optimization of oral
vancomycin-eudragit RS nanoparticles using response surface methodology. Iranian J
Pharmaceut Res. 2012;11(4):1001–12.
114. Mazzarino L, Travelet C, Ortega-Murillo S, Otsuka I, Pignot-Paintrand I, Lemos-Senna E,
et al. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive
applications. J. Colloid Interface Sci. 2012;370(1):58–66.
115. Cascone MG, Lazzeri L, Carmignani C, Zhu Z. Gelatin nanoparticles produced by a simple
W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med. 2002;13(5):523–6.
116. Moradhaseli S, Mirakabadi AZ, Sarzaeem A, Dounighi NM, Soheily S, Borumand
MR. Preparation and characterization of sodium alginate nanoparticles containing ICD-85
(venom derived peptides). Int J Innov Appl Stud. 2013;4(3):534–42.
117. Noorani L, Stenzel M, Liang R, Pourgholami MH, Morris DL. Albumin nanoparticles increase
the anticancer efficacy of albendazole in ovarian cancer xenograft model. J Nanobiotechnol.
2015;13(1):1.
118. Dubey N, Varshney R, Shukla J, Ganeshpurkar A, Hazari PP, Bandopadhaya GP, et al.
Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor
targeted delivery of somatostatin analog. Drug Deliv. 2012;19(3):132–42.
119. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, et al. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007;
28(5):869–76.
120. Zou W, Liu C, Chen Z, Zhang N. Preparation and characterization of cationic PLA-PEG
nanoparticles for delivery of plasmid DNA. Nanoscale Res Lett. 2009;4(9):982.
121. Bathool A, Vishakante GD, Khan MS, Shivakumar H. Development and characterization of
atorvastatin calcium loaded chitosan nanoparticles for sustain drug delivery. Adv Mater Lett.
2012;3(6):466–70.
122. Xue Y, Xu X, Zhang X-Q, Farokhzad OC, Langer R. Preventing diet-induced obesity in mice
by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl
Acad Sci. 2016;113(20):5552–7.
123. Chen H, Ng JP, Tan Y, McGrath K, Bishop DP, Oliver B, et al. Gold nanoparticles improve
metabolic profile of mice fed a high-fat diet. J Nanobiotechnol. 2018;16(1):11.
124. Chen C-C, Tsai T-H, Huang Z-R, Fang J-Y. Effects of lipophilic emulsifiers on the oral
administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 2010;74(3):474–82.
125. Auwal S, Zarei M, Tan C, Basri M, Saari N. Improved in vivo efficacy of anti-hypertensive
biopeptides encapsulated in chitosan nanoparticles fabricated by ionotropic gelation on spontaneously hypertensive rats. Nanomaterials. 2017;7(12):421.
126. Auwal SM, Zarei M, Tan CP, Basri M, Saari N. Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE)-inhibitory biopeptides by chitosan nanoparticles optimized using box-Behnken design. Sci Rep. 2018;8(1):10411.
127. Maximov V, Reukov V, Barry J, Cochrane C, Vertegel A. Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia. Nanotechnology.
2010;21(26):265103.
25 Role of Nanoparticles in the Management of Metabolic Disorders